Literature DB >> 13293406

TREATMENT of malignant hypertension.

.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy

Mesh：

Year:  1956        PMID： 13293406      PMCID： PMC1979209     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  11 in total

1.  Control of blood-pressure by combined action of reserpine and pentapyrrolidinium.

Authors:  F H SMIRK; A E DOYLE; E G McQUEEN
Journal:  Lancet       Date:  1954-07-24       Impact factor: 79.321

2.  Parenteral hexamethonium in hypertension.

Authors:  B MORRISON
Journal:  Br Med J       Date:  1953-06-13

3.  The natural history of hypertension.

Authors:  G W PICKERING
Journal:  Br Med Bull       Date:  1952       Impact factor: 4.291

4.  Clinical studies on bilateral complete adrenalectomy in patients with severe hypertensive vascular disease.

Authors:  G W THORN; J H HARRISON; J P MERRILL; M G CRISCITIELLO; T F FRAWLEY; J T FINKENSTAEDT
Journal:  Ann Intern Med       Date:  1952-11       Impact factor: 25.391

5.  Studies on the control of hypertension by hyphex. V. Effects on the course of the malignant stage.

Authors:  H A SCHROEDER; J D MORROW; H M PERRY
Journal:  Circulation       Date:  1954-09       Impact factor: 29.690

6.  The management of hypertension.

Authors:  J McMICHAEL
Journal:  Br Med J       Date:  1952-05-03

7.  Sympathectomy for hypertension.

Authors:  S M CHRIS
Journal:  Br Med J       Date:  1951-03-31

8.  Bilateral adrenalectomy in malignant hypertension and diabetes.

Authors:  D M GREEN; J N NELSON; G A DODDS; R E SMALLEY
Journal:  J Am Med Assoc       Date:  1950-10-07

9.  Action of a new methonium compound in arterial hypertension; pentamethylene 1 : 5-bis-n-(n-methyl-pyrrolidinium) bitartrate (M. & B. 2050A).

Authors:  F H SMIRK
Journal:  Lancet       Date:  1953-03-07       Impact factor: 79.321

10.  Results of methonium treatment of hypertensive patients, based on 250 cases treated for periods up to 3 1/2 years including 28 with malignant hypertension.

Authors:  F H SMIRK
Journal:  Br Med J       Date:  1954-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.